Aggressive potassium supplementation and targeted therapy led to 91.7% complete neurological recovery in ICU patients with hypokalemic periodic paralysis, with 41.7% requiring mechanical ventilation and no baseline potassium level predicting respiratory failure.
Observational (n=12)
No
Does admission potassium level predict the need for mechanical ventilation in ICU patients with hypokalemic periodic paralysis?
In critically ill patients with hypokalemic periodic paralysis, the need for mechanical ventilation is high but not predicted by admission potassium levels, necessitating vigilant respiratory monitoring regardless of laboratory values.
Absolute Event Rate: 41.7% vs 58.3%
p-value: p=0.87 for difference in potassium levels between MV+ and MV- groups
Background: Hypokalemic periodic paralysis (HPP) presenting as acute quadriparesis is a neuromuscular emergency. While its etiology is described in general wards, its severe "critical care phenotype" in the intensive care unit (ICU) remains poorly characterized. We aimed to define this phenotype by analyzing the clinical profile, etiological spectrum, and predictors of life-threatening severity. Methods: A retrospective study was conducted of 12 patients (nine male, three female; median age: 31.5 years) admitted to a tertiary ICU (2015-2021) with acute quadriparesis and hypokalemia (median potassium: 1.75 mmol/L). We analyzed management and outcomes and compared patients requiring mechanical ventilation (MV+) with those who did not (MV−) using distribution-appropriate statistical methods to identify factors associated with respiratory failure. Results: All patients presented with acute flaccid quadriparesis and areflexia. Five (41.7%) required invasive mechanical ventilation, defining a severe "critical care phenotype." A secondary cause was identified in eight patients (66.7%), including thyrotoxicosis (n=2), distal renal tubular acidosis (n=2), primary hyperaldosteronism, sepsis, dengue fever, and gastroenteritis. Critically, the need for mechanical ventilation was not associated with the degree of hypokalemia (MV+ 1.7 mmol/L vs. MV- 1.7 mmol/L, p=0.87) or other baseline characteristics. With potassium supplementation and targeted therapy, 11 patients (91.7%) achieved complete neurological recovery; one death occurred in a patient with sepsis. Conclusion: HPP in the ICU represents a distinct critical care phenotype with a high risk of respiratory failure. As the requirement for mechanical ventilation was not predicted by admission potassium levels, vigilant monitoring for respiratory muscle fatigue is warranted in all cases. Favorable outcomes are achievable with prompt correction and treatment of the underlying cause, reinforcing that HPP is a reversible ICU emergency.
Pande et al. (Wed,) conducted a observational in Adults with acute flaccid quadriparesis due to hypokalemic periodic paralysis admitted to ICU (n=12). Aggressive intravenous potassium supplementation with targeted therapy for underlying etiology vs. No mechanical ventilation group with similar potassium supplementation and targeted therapy was evaluated on Requirement of invasive mechanical ventilation indicating severe respiratory failure (p=0.87 for difference in potassium levels between MV+ and MV- groups). Aggressive potassium supplementation and targeted therapy led to 91.7% complete neurological recovery in ICU patients with hypokalemic periodic paralysis, with 41.7% requiring mechanical ventilation and no baseline potassium level predicting respiratory failure.